<DOC>
	<DOCNO>NCT00904254</DOCNO>
	<brief_summary>The primary objective study proof concept EP 1645 diagnostic tool carotid artery atherosclerosis plaque instability ass safety tolerability diagnostic agent , monoclonal antibody fragment ( Fab ' ) conjugate diagnostic radionuclide 99mTc . Safety tolerability determine adverse event ( AEs ) observe report upon administration product absorb dose radiation .</brief_summary>
	<brief_title>The Use Anti-CD4 mAb-Fragment Imaging Local Inflammation Patients With Carotid Artery Stenosis</brief_title>
	<detailed_description>For evaluation atherosclerosis carotid artery sonographic measurement plaque burden use . This method advantage investigation carotid artery since region easy accessible investigation . However , allow evaluation vessel remote body surface , , instance , coronary artery . A method non-invasive reliable evaluation artery need . Also distinction vulnerable stable plaque great clinical relevance . A quantifiable method determination effect new therapeutic approach would highly appreciate . It expect , new antibody fragment radioactive linkage allow display image activity distribution disease . Due fact patient atherosclerotic change carotid artery allow compare activity clinical sign disease , proof concept study ( phase II study ) perform patient asymptomatic symptomatic carotid artery stenosis .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Carotid Stenosis</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Immunoglobulin Fab Fragments</mesh_term>
	<criteria>male female either symptomatic ( &gt; 60 % ) asymptomatic ( &gt; 80 % ) carotid artery stenosis 50 80 year age Symptomatic stenosis A. carotis interna define occurence focal ischemic symptom area supply vessel , occurence transischemic attack ( TIA ) , occurence focal neurologic dysfunction unilateral blindness . informed consent accordance ICH GCP ยง 40 AMG StrahlSchV sonography status patient present ( printout available ) patient available carotid surgery within 3 month diagnosis carotid artery stenosis In patient bilateral disease , stenosis consider surgery include endpoint evaluation . patient &gt; 80 year major disease cardiovascular system , respiratory system , hepatobiliary system CNS , prevent patient study participation opinion investigator hepatic ( transaminase &gt; 3 x norm ) renal ( serum creatinine increase &gt; 2x norm ) insufficiency regular drug intake biologics . Intake drug must judge investigator must strictly document previous administration xenogenous protein history anaphylactic reaction drug administer parenteral pathway previous participation radiopharmaceutical drug trial ( unless effective dose acquire participation current trial remain 10 mSv ) participation clinical drug trial within 3 month prior enrolment woman childbearing potential ( childbearing potential rule one following : least 2 year past menopause , hysterectomy , bilateral oophorectomy , bilateral tubal ligation ) Patients present clinical sign severe systemic infection ( CRP &gt; 50 mg/dl ) Carotid Surgery ( TEA ) possible within time frame 7 day image Patients bilateral carotid stenosis clinically regard critical angiologist .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>cerebrovascular disorder</keyword>
	<keyword>symptomatic carotid artery stenosis</keyword>
	<keyword>asymptomatic carotid artery stenosis</keyword>
	<keyword>monoclonal antibody</keyword>
	<keyword>diagnostics</keyword>
	<keyword>molecular target</keyword>
	<keyword>immunoglobulin Fab fragment</keyword>
	<keyword>physiological effect drug</keyword>
	<keyword>Tc99m-pertechnetate</keyword>
	<keyword>Fab-fragment Anti-human CD4</keyword>
	<keyword>Antibodies , Monoclonal</keyword>
	<keyword>Antibodies</keyword>
</DOC>